Ads
related to: biontech stock price history
Search results
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 14 hours agoOn BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the...
BioNTech SE's (NASDAQ:BNTX) market cap surged US$4.0b last week, private equity firms who have a lot...
Simply Wall St. via Yahoo Finance· 1 year agoIf you want to know who really controls BioNTech SE (NASDAQ:BNTX), then you'll have to look at the...
BioNTech's (BNTX) Earnings & Revenues Miss Estimates in Q2
Zacks via Yahoo Finance· 2 years agoGermany-based BioNTech SE BNTX is an immunotherapy company that focuses on the development of novel...
What Is The Ownership Structure Like For BioNTech SE (NASDAQ:BNTX)?
Simply Wall St. via Yahoo Finance· 2 years agoA look at the shareholders of BioNTech SE (NASDAQ:BNTX) can tell us which group is most powerful....
Is a Beat in Store for BioNTech (BNTX) This Earnings Season?
Zacks via Yahoo Finance· 2 years agoOn BioNTech's (BNTX) second-quarter earnings call, investors are expected to focus on the sales...
Pfizer (PFE) & BioNTech Get CHMP Nod for Updated Covid-19 Jab
Zacks via Yahoo Finance· 8 months agoPfizer PFE and partner BioNTech BNTX announced that the Committee for Medicinal Products for Human...
Here's Why We Think BioNTech (NASDAQ:BNTX) Is Well Worth Watching
Simply Wall St. via Yahoo Finance· 1 year agoInvestors are often guided by the idea of discovering 'the next big thing', even if that means...
Novo Nordisk (NVO) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoNovo Nordisk A/S NVO is scheduled to release its second-quarter 2022 results on Aug 4. The company’s...
The Chef's Warehouse and AZEK have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – June 30, 2022 – Zacks Equity Research shares The Chef's...
BioNTech Starts Dosing In Herpes Vaccine Candidate Study
Benzinga via Yahoo Finance· 1 year agoBioNTech SE (NASDAQ: BNTX) has dosed in a first-in-human Phase 1 clinical research study with...
